Back
Intellia Therapeutics Quote, Financials, Valuation and Earnings
Sell
45
NTLA
Intellia Therapeutics
Last Price:
26.24
Seasonality Move:
33.25%
7 Day Trial
ALL ACCESS PASS
$
7
Intellia Therapeutics Price Quote
$26.24
+0.02 (+0.27%)
(Updated: May 18, 2024 at 5:50 AM ET)
Intellia Therapeutics Key Stats
Sell
45
Intellia Therapeutics (NTLA)
is a Sell
Day range:
$25.81 - $26.55
52-week range:
$19.37 - $47.48
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
45.52
P/B ratio:
2.44%
Volume:
1.1M
Avg. volume:
1.3M
1-year change:
-40.14%
Market cap:
$2.5B
Revenue:
$36.3M
EPS:
$-5.36
How Much Does Intellia Therapeutics Make?
-
How Much Are Intellia Therapeutics's Sales Annually?
NTLA Revenues are $36.3M -
How Much Profit Does Intellia Therapeutics's Make A Year?
NTLA net income is -$481.2M
Is Intellia Therapeutics Growing As A Company?
-
What Is Intellia Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 1.3% -
What Is Intellia Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Intellia Therapeutics Stock Price Performance
-
Did Intellia Therapeutics Stock Go Up Last Month?
Intellia Therapeutics share price went up by 21.95% last month -
Did NTLA's Share Price Rise Over The Last Year?
NTLA share price fell by -40.14% over the past 1 year
What Is Intellia Therapeutics 52-Week High & Low?
-
What Is Intellia Therapeutics’s 52-Week High Share Price?
Intellia Therapeutics has traded as high as $47.48 over the past 52 weeks -
What Is Intellia Therapeutics’s 52-Week Low Share Price?
Intellia Therapeutics has traded as low as $19.37 over the past 52 weeks
Intellia Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Intellia Therapeutics?
-
How Much Debt Does Intellia Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Intellia Therapeutics Have?
Cash and short term investments quarterly total is $791.3M -
What Is Intellia Therapeutics’s Book Value Per Share?
Book value per share is 10.76
Is Intellia Therapeutics Cash Flow Positive?
-
What Is NTLA Cash Flow From Operations?
Cash flow from operations (TTM) is -$405.4M -
What Is Intellia Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $188.1M -
What Is Intellia Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $96.8M
Intellia Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
NTLA return on invested capital is -44.79% -
What Is Intellia Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -37.09% -
What Is NTLA Return On Equity?
ROE is a measure of profitability and is -44.79%
Intellia Therapeutics Earnings Date & Stock Price
-
What Is Intellia Therapeutics's Stock Price Today?
A single share of NTLA can be purchased today for 26.22 -
What Is Intellia Therapeutics’s Stock Symbol?
Intellia Therapeutics trades on the nasdaq under the ticker symbol: NTLA -
When Is Intellia Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Intellia Therapeutics is scheduled on August 2, 2024 -
When Is NTLA's next ex-dividend date?
Intellia Therapeutics's next ex-dividend date is May 20, 2024 -
How To Buy Intellia Therapeutics Stock?
You can buy Intellia Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Intellia Therapeutics Competitors
-
Who Are Intellia Therapeutics's Competitors?
Below is a list of companies who compete with Intellia Therapeutics or are related in some way:
Intellia Therapeutics Dividend Yield
Data Unavailable
Intellia Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 16.24% |
| Revenue: | 129.53% | 219.19% |
Analyst Recommendations
| Buy Recommendations: | 17 |
|---|---|
| Hold Recommendations: | 6 |
| Sell Recommendations: | 0 |
| Price Target: | 70.26 |
| Upside from Last Price: | 167.96% |